Literature DB >> 8383395

Pathogenetic differences between coxsackie A and B virus infections in newborn mice.

T Hyypiä1, M Kallajoki, M Maaronen, G Stanway, R Kandolf, P Auvinen, H Kalimo.   

Abstract

Coxsackieviruses are divided into A and B subgroups on the basis of their pathogenicity in newborn mice. Although used in the classification of these viruses, our understanding of the details of the infection is incomplete due to the lack of sensitive and specific techniques to localize the viruses in affected tissue. We have used in situ hybridization to detect coxsackievirus genomes in tissues of newborn mice after infection by five serotypes (A2, A9, A21, B3 and B4) through different administration routes. Our results indicate that coxsackie A viruses are able to affect both skeletal and heart muscle while the coxsackievirus B subgroup infects a wide range of tissues. In addition to striated muscle these include central nervous system, liver, exocrine pancreas and brown fat. This model will make it possible to analyze molecular factors determining tissue tropism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383395     DOI: 10.1016/0168-1702(93)90113-2

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  14 in total

1.  Molecular determinants of disease in coxsackievirus B1 murine infection.

Authors:  Javier O Cifuente; María F Ferrer; Carolina Jaquenod de Giusti; Wen-Chao Song; Víctor Romanowski; Susan L Hafenstein; Ricardo M Gómez
Journal:  J Med Virol       Date:  2011-09       Impact factor: 2.327

2.  Efficient RGD-independent entry process of coxsackievirus A9.

Authors:  M Roivainen; L Piirainen; T Hovi
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Neural stem cell depletion and CNS developmental defects after enteroviral infection.

Authors:  Chelsea M Ruller; Jenna M Tabor-Godwin; Donn A Van Deren; Scott M Robinson; Sonia Maciejewski; Shea Gluhm; Paul E Gilbert; Naili An; Natalie A Gude; Mark A Sussman; J Lindsay Whitton; Ralph Feuer
Journal:  Am J Pathol       Date:  2011-12-31       Impact factor: 4.307

Review 4.  Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Jay Reddy
Journal:  Int J Cardiol       Date:  2014-10-18       Impact factor: 4.164

5.  Myeloma xenograft destruction by a nonviral vector delivering oncolytic infectious nucleic acid.

Authors:  Elizabeth M Hadac; Elizabeth J Kelly; Stephen J Russell
Journal:  Mol Ther       Date:  2011-04-19       Impact factor: 11.454

6.  The role of B lymphocytes in coxsackievirus B3 infection.

Authors:  I Mena; C M Perry; S Harkins; F Rodriguez; J Gebhard; J L Whitton
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

7.  Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance.

Authors:  J R Gebhard; C M Perry; S Harkins; T Lane; I Mena; V C Asensio; I L Campbell; J L Whitton
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  An outbreak of aseptic meningitis caused by coxsackievirus A9 in Gansu, the People's Republic of China.

Authors:  Aili Cui; Deshan Yu; Zhen Zhu; Lei Meng; Hui Li; Jianfeng Liu; Guiyan Liu; Naiying Mao; Wenbo Xu
Journal:  Virol J       Date:  2010-04-06       Impact factor: 4.099

9.  Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Stephanie Harkins; Daniel E Hassett; J Lindsay Whitton
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  A neonatal mouse model of coxsackievirus A16 for vaccine evaluation.

Authors:  Qunying Mao; Yiping Wang; Rong Gao; Jie Shao; Xin Yao; Shuhui Lang; Chao Wang; Panyong Mao; Zhenglun Liang; Junzhi Wang
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.